Tue, Nov 25, 2014, 11:41 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • tkg1078813 tkg1078813 Apr 13, 2013 9:11 AM Flag

    Isn't this really the basic question re: Q1...

    Were the Acthar quarterly sales great enough to offset the Biovectra acquisition and Medicaid rebate % issue that will be reflected in this quarter? Place your bets!

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • CMS Revenue will skyrocket from 0% to 76.9%, get that thru yer thick head.
      Biovectra purchase is NOT an expense, but a depreciable asset my friend.

    • tkg: sounds as if you, like Favus, don't understand about the Medicaid/care rebates.

      Once again, the latter are now a POSITIVE for QCOR earnings. While there may be legitimate controversy about the exact timing of the flows (but not much), the previous situation of Q needing to rebate (ie. give back) 100% of M payments has now been changed to needing to rebate only 23.1%. So, shorts will be best advised to stop misrepresenting this.

    • Bottom line is that it's already underpriced relative to lower reimbursements and the cost of Biovectra. They have a ton of cash. QCOR has been under unwarranted down pressure ever since the AETNA reimbursement controversy. If earnings are weak, it may fall some more, even though its already priced in.

      I can't believe that there's a 50% short position of the float. Unbelievable. The slightest good news...even expected and not negative news, could propel this to $36-$40 with short covering.

      My opinion is that we will come back and easily hit above $30 early next week.

      Sentiment: Strong Buy

    • it depends upon your time horizon. I hope they have a good quarter, but am focused on the future...the rest of 2013, and into 2014.
      And if this quarter is not impressive enough for shorts and weak longs, I will probably continue adding on significant pull-backs.
      Long term investors are able to buy at embarrassing prices now, all due to perceived "uncertainty". That is the time to buy if one really "knows" the QCOR story. If there were no uncertainty qcor would probably be selling in the $100/share range (9x PE now...just add 18x multiple-which is still low+PEG).
      Plus I am collecting an average of 3 1/2% to sit and wait.
      And I've got the patience to wait.

      Sentiment: Strong Buy

 
QCOR
93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.